 Featured News June 16, 2008
Med BioGene Expands Lymphoma Collaboration; Becomes Founding Corporate Collaborator of Translational Working Group in Hematologic Malignancies
May 29, 2008
Med BioGene Appoints Diagnostics Industry Veteran Dr. Heiner Dreismann to Board of Directors
April 23, 2008
Med BioGene and University Health Network Collaborate to Commercialize Critical Lung Cancer Prognostic Test
|
Corporate Information Med BioGene was founded in 2002 and its state-of-the-art laboratory and offices are located in Discovery Park on the University of British Columbia campus. Med BioGene's common shares are listed on the TSX Venture Exchange under the symbol "MBI".
|
E-MAIL ALERTS
Subscribe to our e-mail news alerts
Quick Facts
Download our facts sheet
|
Home 
© Copyright 2006 - Med BioGene Inc. - Legal Disclaimer